BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ · Healthcare · Biotechnology · US
$63.94
−1.75%Forward multiples
Based on analyst estimates
- P/E forward
- 10.34x
- P/E 2026E
- 12.85x
- P/E 2027E
- 9.70x
- P/E 2028E
- 8.22x
- P/S forward
- 2.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 168.26x
- PEG TTM
- 0.11x
- Price / book
- 1.96x
- Price / sales
- 3.63x
- Price / cash flow
- 14.44x
Enterprise value
- Enterprise value
- $15.7B
- EV / sales
- 4.61x
- EV / EBITDA
- 40.72x
- EV / EBIT
- 57.47x
- Market cap
- $12.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026